Zimmer Biomet Holdings Current Ratio 2006-2018 | ZBH

Current and historical current ratio for Zimmer Biomet Holdings (ZBH) from 2006 to 2018. Current ratio can be defined as a liquidity ratio that measures a company's ability to pay short-term obligations. Zimmer Biomet Holdings current ratio for the three months ending December 31, 2018 was 1.83.
Zimmer Biomet Holdings Current Ratio Historical Data
Date Current Assets Current Liabilities Current Ratio
2018-12-31 $4.43B $2.42B 1.83
2018-09-30 $4.51B $2.39B 1.89
2018-06-30 $4.48B $1.85B 2.41
2018-03-31 $5.78B $3.43B 1.69
2017-12-31 $4.57B $3.07B 1.49
2017-09-30 $4.43B $3.01B 1.47
2017-06-30 $4.42B $3.00B 1.48
2017-03-31 $5.08B $2.66B 1.91
2016-12-31 $4.66B $2.38B 1.96
2016-09-30 $4.70B $2.31B 2.03
2016-06-30 $5.05B $2.10B 2.40
2016-03-31 $5.08B $1.52B 3.36
2015-12-31 $5.85B $1.62B 3.62
2015-09-30 $6.40B $1.79B 3.58
2015-06-30 $6.75B $2.16B 3.12
2015-03-31 $11.92B $0.91B 13.12
2014-12-31 $4.31B $1.02B 4.21
2014-09-30 $4.33B $1.09B 3.96
2014-06-30 $4.23B $0.95B 4.44
2014-03-31 $4.05B $0.92B 4.41
2013-12-31 $4.20B $1.03B 4.07
2013-09-30 $3.84B $0.80B 4.77
2013-06-30 $3.59B $0.80B 4.47
2013-03-31 $3.46B $0.76B 4.54
2012-12-31 $3.71B $0.87B 4.28
2012-09-30 $3.63B $0.76B 4.81
2012-06-30 $3.48B $0.68B 5.09
2012-03-31 $3.32B $0.86B 3.86
2011-12-31 $3.28B $0.87B 3.78
2011-09-30 $3.07B $0.68B 4.56
2011-06-30 $3.11B $0.68B 4.58
2011-03-31 $3.03B $0.71B 4.25
2010-12-31 $3.01B $0.70B 4.28
2010-09-30 $3.01B $0.70B 4.31
2010-06-30 $2.98B $0.60B 4.96
2010-03-31 $2.87B $0.66B 4.39
2009-12-31 $2.74B $0.69B 3.96
2009-09-30 $2.45B $0.68B 3.62
2009-06-30 $2.33B $0.67B 3.48
2009-03-31 $2.20B $0.70B 3.12
2008-12-31 $2.18B $0.77B 2.83
2008-09-30 $2.33B $0.84B 2.78
2008-06-30 $2.21B $0.81B 2.73
2008-03-31 $2.22B $0.79B 2.82
2007-12-31 $2.08B $0.75B 2.78
2007-09-30 $1.90B $0.71B 2.69
2007-06-30 $1.95B $0.64B 3.03
2007-03-31 $1.89B $0.60B 3.15
2006-12-31 $1.75B $0.63B 2.78
2006-09-30 $1.71B $0.68B 2.51
2006-06-30 $1.79B $0.63B 2.84
2006-03-31 $1.83B $0.57B 3.21
2005-12-31 $1.58B $0.61B 2.60
2005-09-30 $1.50B $0.66B 2.29
2005-06-30 $1.49B $0.61B 2.43
2005-03-31 $1.48B $0.61B 2.43
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $25.679B $7.933B
Zimmer Biomet Holdings, Inc. is a musculoskeletal healthcare company. The company design, manufacture and market orthopaedic reconstructive products; sports medicine, biologics, extremities and trauma products; spine, bone healing, craniomaxillofacial and thoracic products; dental implants; and related surgical products. Zimmer Biomet Holdings, Inc., formerly known as Zimmer Holdings, Inc., is based in Warsaw, United States.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $134.159B 26.52
Medtronic (MDT) Ireland $115.540B 16.89
Stryker (SYK) United States $70.532B 25.86
Boston Scientific (BSX) United States $50.294B 24.44
Baxter (BAX) United States $39.673B 25.45
Smith & Nephew SNATS (SNN) United Kingdom $17.031B 0.00
ResMed (RMD) United States $14.595B 27.68
Canopy Growth (CGC) Canada $13.948B 0.00
Aurora Cannabis (ACB) Canada $8.997B 63.43
Bio-Rad Laboratories (BIO) United States $8.983B 51.53
Perrigo (PRGO) Ireland $6.875B 11.15
Hill-Rom Holdings (HRC) United States $6.733B 20.83
Insulet (PODD) United States $5.339B 1789.80
GW Pharmaceuticals (GWPH) United Kingdom $4.909B 0.00
ICU Medical (ICUI) United States $4.831B 29.92
Haemonetics (HAE) United States $4.331B 38.42
Hutchison China MediTech (HCM) China $4.129B 0.00
Agios Pharmaceuticals (AGIO) United States $3.487B 0.00
Neogen (NEOG) United States $2.954B 48.03
NuVasive (NUVA) United States $2.902B 25.21
Quidel (QDEL) United States $2.529B 22.63
National Vision Holdings (EYE) United States $2.284B 44.92
Aphria (APHA) $2.178B 0.00
Phibro Animal Health (PAHC) United States $1.359B 19.53
HEXO (HEXO) $1.253B 0.00
VAREX IMAGING (VREX) United States $1.238B 24.24
Cardiovascular Systems (CSII) United States $1.210B 868.75
AtriCure (ATRC) United States $1.097B 0.00
Lantheus Holdings (LNTH) United States $0.956B 25.82
Omeros (OMER) United States $0.918B 0.00
PetIQ (PETQ) United States $0.888B 25.40
Cerus (CERS) United States $0.835B 0.00
MacroGenics (MGNX) United States $0.824B 0.00
NanoString Technologies (NSTG) United States $0.764B 0.00
TG Therapeutics (TGTX) United States $0.704B 0.00
Eagle Pharmaceuticals (EGRX) United States $0.696B 23.70
Evolus (EOLS) United States $0.690B 0.00
OraSure Technologies (OSUR) United States $0.614B 26.76
LeMaitre Vascular (LMAT) United States $0.562B 26.76
Surmodics (SRDX) United States $0.550B 79.94
Meridian Bioscience (VIVO) United States $0.539B 16.05
Quanterix (QTRX) United States $0.495B 0.00
Insys Therapeutics (INSY) United States $0.342B 0.00
BioLife Solutions (BLFS) United States $0.319B 131.62
Utah Medical Products (UTMD) United States $0.317B 20.65
Vapotherm (VAPO) United States $0.295B 0.00
Neptune Technologies & Bioresources Inc (NEPT) Canada $0.294B 0.00
Rockwell Medical (RMTI) United States $0.279B 0.00
Owens & Minor (OMI) United States $0.239B 3.27
Cytosorbents (CTSO) United States $0.228B 0.00
Zynex (ZYXI) United States $0.171B 18.31
Chimerix (CMRX) United States $0.138B 0.00
Fonar (FONR) United States $0.124B 6.64
Bovie Medical (APYX) United States $0.124B 0.00
Chembio Diagnostics (CEMI) United States $0.121B 0.00
Surface Oncology (SURF) United States $0.114B 0.00
InfuSystems Holdings (INFU) United States $0.093B 0.00
Female Health (VERU) United States $0.090B 0.00
United-Guardian (UG) United States $0.088B 20.21
Neurotrope (NTRP) United States $0.073B 0.00
CAS Medical Systems (CASM) United States $0.072B 0.00
Oramed Pharmaceuticals (ORMP) United States $0.069B 0.00
Trinity Biotech (TRIB) Ireland $0.068B 20.07
ImmuCell (ICCC) United States $0.044B 0.00
Senestech (SNES) United States $0.033B 0.00
Valeritas Holdings (VLRX) United States $0.032B 0.00
Conatus Pharmaceuticals (CNAT) United States $0.023B 0.00
Myomo (MYO) United States $0.020B 0.00
Capricor Therapeutics (CAPR) United States $0.019B 0.00
InVivo Therapeutics Holdings (NVIV) United States $0.014B 0.00
Cellectar Biosciences (CLRB) United States $0.011B 0.00
Akers Biosciences Inc (AKER) United States $0.009B 0.00
NeuroMetrix (NURO) United States $0.008B 14.57